Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Therapeutics

49.95
+0.43000.87%
Post-market: 49.950.00000.00%16:05 EDT
Volume:861.74K
Turnover:43.06M
Market Cap:3.94B
PE:-10.57
High:50.43
Open:49.88
Low:49.03
Close:49.52
Loading ...

RBC Capital Adjusts PTC Therapeutics Price Target to $63 From $60, Maintains Outperform Rating

MT Newswires Live
·
18 Feb

PTC Therapeutics Inc : RBC Raises Target Price to $63 From $60

THOMSON REUTERS
·
18 Feb

PTC Therapeutics price target raised to $45 from $32 at Citi

TIPRANKS
·
12 Feb

PTC Therapeutics (PTCT) Moves 9.0% Higher: Will This Strength Last?

Zacks
·
04 Feb

Why PTC Therapeutics (PTCT) Stock Is Rallying Today

Insider Monkey
·
04 Feb

Cantor Fitzgerald Sticks to Its Buy Rating for PTC Therapeutics (PTCT)

TIPRANKS
·
03 Feb

PTC Therapeutics price target raised to $113 from $76 at Cantor Fitzgerald

TIPRANKS
·
03 Feb

PTC Therapeutics (PTCT) Receives a Hold from Leerink Partners

TIPRANKS
·
22 Jan

U.S. RESEARCH ROUNDUP- Apple, Murphy USA, UnitedHealth

Reuters
·
21 Jan

Cantor Fitzgerald Sticks to Its Buy Rating for PTC Therapeutics (PTCT)

TIPRANKS
·
15 Jan

PTC Therapeutics Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
15 Jan

Cautious Outlook on PTC Therapeutics Amid Regulatory and Financial Challenges

TIPRANKS
·
15 Jan

BRIEF-Orsini Chosen By PTC Therapeutics As Exclusive Specialty Pharmacy Provider For Adeno-Associated Virus Vector-Based Gene Therapy KEBILIDI™

Reuters
·
14 Jan

Orsini: Chosen by PTC Therapeutics as Exclusive Specialty Pharmacy Provider for Adeno-Associated Virus Vector-Based Gene Therapy Kebilidi

THOMSON REUTERS
·
14 Jan

PTC Therapeutics (PTCT) Gets a Sell from Bank of America Securities

TIPRANKS
·
14 Jan

PTC Therapeutics: Strong Financial Performance and Strategic Advancements Justify Buy Rating

TIPRANKS
·
14 Jan

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
14 Jan

PTC Therapeutics Surpasses Expectations with Strong 2024 Financials and Promising 2025 Outlook

TIPRANKS
·
14 Jan

PTC Therapeutics Surpasses Revenue Guidance for 2024

TIPRANKS
·
14 Jan

PTC Therapeutics sees FY25 revenue $600M-$800M, consensus $963.31M

TIPRANKS
·
13 Jan